Beijing Hotgen Biotech Co., Ltd

06/08/2026

Heart risk doesn't wait—neither should you.

Hotgen's 10-Biomarker Cardio Panel gives you full coverage in one step: early heart attack markers (hs-cTnT, hs-cTnI, CK-MB, MYO, H-FABP), heart failure indicators (NT-proBNP, BNP, ST2), and clot/plaque risks (Lp-PLA2, D-Dimer).

Fast results. Trusted by labs worldwide for 21+ years.

https://www.hotgenbiotech.com

04/08/2026

29/07/2026

Hotgen showcased its innovative immunodiagnostic solutions at ADLM 2026, held from July 28-30 at the Anaheim Convention Center. As a leading IVD company, Hotgen highlighted cutting-edge technologies, fostering global partnerships and driving diagnostic innovation. Discover more about our solutions.

https://www.hotgenbiotech.com/

28/07/2026

I'm Lumen, your IVD Product Advocate from Hotgen.

Liver cancer often hides without symptoms. Our trusted solution combines AFP, AFP-L3%, and DCP—three biomarkers that catch HCC early, even months before, with accuracy up to 96%.

Early detection saves lives.

https://www.hotgenbiotech.com

28/07/2026

Early detection saves lives.

From hepatitis to liver cancer, the progression is silent—but not inevitable. Hotgen's Precision Liver Health Panel (CK18-M30/M65, GP73, AFP, AFP-L3%, DCP) enables early intervention at reversible stages like MASLD and MASH, before cirrhosis or HCC develop.

Backed by CLIA technology. High sensitivity, clinical confidence.

Because your liver deserves early warning, not emergency.

https://www.hotgenbiotech.com

21/07/2026

From July 17–19, 2026, the 21st DDA Tamil Nadu State Annual Conference was held in Kodaikanal, India. Organized by the Madurai Chapter, this event drew over 200 diagnostic distributors, representing a vast network of healthcare institutions. Hotgen showcased its immunodiagnostic solutions.

https://www.hotgenbiotech.com/strengthening-channel-partnerships-across-south-asia-hotgen-showcases-at-the-dda-tamil-nadu-annual-conference.html

20/07/2026

Early Detection Saves Lives — From Hepatitis to Hepatocellular Carcinoma (HCC)

MASLD affects 38% of adults globally — rising to 65% in Type 2 Diabetes. Without intervention, it progresses from healthy liver → MASLD → MASH → Cirrhosis → HCC, with irreversible stages and high mortality risk.

Don’t wait for symptoms. Detect liver damage early with our precision panel:
✅ CK18 – Liver cell apoptosis& MASH assessment
✅ GP73 – Liver injury & fibrosis marker
✅ AFP + AFP-L3% +DCP– Improved secificity & sensitivity for HCC assessment

Why it matters:
• Early detection = reversible stages (MASLD/MASH) → better outcomes

• Late-stage cirrhosis/HCC = transplant or death. Our test guides timely intervention.

• Backed by global prevalence data & clinical guidelines (Mediterranean diet, weight loss, Resmetirom for MASH).

Act now. Monitor your liver health before it’s too late.
Your liver deserves early warning — not emergency.

— Precision Liver Health Panel: CK18 GP73 AFP AFP-L3%
DCP —

(Ideal for high-risk patients: diabetes, obesity, MASLD, family history)

10/07/2026

📍 Visit Hotgen at Booth #1!​
🗓️ July 17–19, 2026​
🏨 Kodai International Hotel, Kodaikanal, Tamil Nadu, India

Discover our FULL-SCENARIO IMMUNOASSAY SOLUTIONS​ — featuring UPT2800, MQ60 smart, C800 & C2100.

🤝 Don't miss out — stop by and let's innovate together!

07/07/2026

Hotgen is heading to Bangkok and Anaheim this July!

Visit us at WHX LABS BANGKOK (Booth L40, July 8–10) and ADLM 2026 (Booth #4020, July 28–30) to explore our MONO-TEST CLIA analyzers, automatic CLIA systems, and UPT-POCT solutions—trusted in 50+ countries with 18,000+ units installed globally. See you there!

https://www.hotgenbiotech.com

-POCT

02/07/2026

🚀 Meet HOTGEN at ADLM 2026!

Comprehensive POCT & Immunoassay Solutions

Join us at ADLM 2026 to discover Hotgen's latest innovations in diagnostics, from rapid POCT to advanced CLIA solutions.

📍 Booth #4020
📅 July 28–30, 2026
📍 Anaheim Convention Center, California, USA

We look forward to meeting you and exploring new opportunities together!